( Indian pharma major Dr. Reddy's Laborat...)Dr. Reddy's To Invest $100 Mn In Andhra,Health

Indian pharma major Dr. Reddy's Laboratories (DRL) is all set to invest nearly Rs. 4.5 billion ($100 million) as part of their expansion drive in Andhra Pradesh, the company's home state. //

'As part of our plan, $100 million will be invested within the next 18 months for increasing our capacity in the field of formulations, Active Pharmaceuticals Ingredients (API) and Custom Pharmaceutical Business (CPB),' said Satish Reddy, managing director of Dr. Reddy's Laboratories.

Reddy, also the company's chief operating officer, said they would utilise part of the funds raised by issuing shares.

'The company's expansion will take place in their current establishments at Hyderabad and Visakhapatnam. Besides, we are also looking at setting up two new plants in Andhra Pradesh as part our Special Economic Zone plan,' Reddy told IANS at the New Zealand High Commission here.

Reddy was in the capital Thursday to announce the launch of Polypill - a first-of-its-kind tablet to tackle heart diseases, in the second half of 2007.

The new medicine is a cocktail of four drugs and has jointly been developed by experts at DRL and Auckland University, New Zealand. It is currently under trial in India.

India records nearly 2.8 million deaths a year from cardio-vascular diseases.

He however, refused to divulge details of the investment for the two new plants.

'We have received approval from the central government in principle, but it would be too early to give details of the investment amount.'

Raghu Cidambi, advisor to DRL, said: 'As per our plan, the company will roll out eight billion generic tablets per annum by the end of 2007 and the capacity will be further enhanced to 16 billion tablets per year by early 2009.'

'This drug would reduce the heart attack risk by almost 65 percent as it is capable of reducing cholesterol level and control blood pressure. In India, our focus is t
'"/>




Page: 1 2
Related medicine news :

1. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
2. Dr Reddys Launches Generic Version Of Mercks Proscar Tablets
3. Dr. Reddys To Launch Polypill For Treating Heart Disease
4. Dr Reddys Eyeing for Generics Arm of Merck
5. Invest on gym memberships
6. Investigations That Help Detect Lung Disease
7. Sitagliptin, Under Investigation For Type 2 Diabetes
8. China Doubles Its Investment In AIDS/HIV Treatment.
9. Biocon To Raise Its Investment In Scotland
10. Cocoa Treats: Chocolates, as a Health Investment? Chew on this!
11. President Bush Urges Citizens to Invest In Health Savings Account (HSAs)